TGA
We’ve updated the Listed Medicine Compliance Reports database with the results of compliance reviews covering 32 listed medicines, including:
- 19 sunscreens:
- These sunscreens were targeted for review because they used the same base formulation as Ultra Violette Lean Screen SPF 50+ sunscreen (formerly AUST L 332788) that showed lower than claimed Sun Protection Factor (SPF) testing results, following the 2025 CHOICE report on SPF testing of a range of sunscreens on the Australian market.
- Following the review, all 19 sunscreens have been cancelled from the Australian Register of Therapeutic Goods (ARTG) and recalled.
- 13 other products, including:
- Medicines containing phenylalanine
- Medicines reviewed to check whether they meet stability requirements
- Medicines with non-permitted health claims about:
- cardiovascular, neurodegenerative, and metabolic diseases,
- iron deficiency,
- mycosis, vaginosis, intimate discomfort or regeneration of vaginal microbiota,
- nicotinamide adenine dinucleotide (NAD, NAD+, NADH) or nicotinamide mononucleotide (NMN), and
- weight loss.
- Following the review, 9 of these products have been cancelled from the ARTG and 2 have been recalled.
/Public Release. View in full here.
